Industry reports
Editor highlights

Disease and Therapy Review Rheumatoid Arthritis

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

World Therapy: Glomerulonephritis – Pipeline Review, H1 2012

World Therapy: Glomerulonephritis – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • March 2014
  • 55 pages

This report provides data on the therapeutic development for Glomerulonephritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glomerulonephritis. 'Glomerulonephritis - Pipeline Review, ...

Industries: Pathology | Countries: China, World

3SBio Inc. (Symbol:SSRX) SWOT Analysis, Strategy, Revenues and Profits

3SBio Inc. (Symbol:SSRX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • March 2014
  • 37 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. 3SBio Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: China

2014 Deep Research Report on Global and China Breast Localization Wire Industry

2014 Deep Research Report on Global and China Breast Localization Wire Industry

  • $ 2 200
  • Industry report
  • by QY Research Group
  • March 2014
  • 179 pages

Summary "2014 Deep Research Report on Global and China Breast Localization Wire Industry" was professional and depth research report on Global and China Breast Localization Wire industry. The report firstly introduced Breast Localization Wire basic information included Breast Localization Wire definition ...

Industries: Pathology | Countries: China, World

Measles - Pipeline Review, H1 2014

Measles - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • February 2014
  • 58 pages

Measles - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Measles - Pipeline Review, H1 2014', provides an overview of the Measles's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Measles, complete with comparative analysis at various ...

Industries: Pathology | Countries: World, India, China, United States

World Therapy: Glaucoma – Pipeline Review, H1 2012

World Therapy: Glaucoma – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • February 2014
  • 207 pages

This report provides data on the therapeutic development for Glaucoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glaucoma. 'Glaucoma - Pipeline Review, H1 2012' is built using data ...

Industries: Pathology | Countries: World, China

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • February 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States, Spain, South Korea, Japan, China

Prochymal (Crohn's Disease) - Forecast and Market Analysis to 2022

Prochymal (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 55 pages

Prochymal (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they ...

Industries: Pathology | Countries: Canada, World, United States, India, China

Stelara (Crohn's Disease) - Forecast and Market Analysis to 2022

Stelara (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 60 pages

Stelara (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they ...

Industries: Pathology | Countries: Canada, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, India, China, Europe

Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022

Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 47 pages

Tysabri (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they ...

Industries: Pathology | Countries: China, World, Spain, Italy, France, Germany, United States, Canada, India, Europe

Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022

Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • January 2014
  • 58 pages

Vercirnon (Crohn's Disease) - Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon. These compounds will challenge the current biologics in an attempt to dislodge the stronghold of the TNF inhibitors, as they ...

Industries: Pathology | Countries: Canada, World, Spain, Italy, France, Germany, United States, United Kingdom, India, China, Europe

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.